A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Clinical trial NCT01733004 · COMPLETED
Trial details
- NCT number
- NCT01733004
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2016-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.